


14.00-15.00

15.00-16.30
CAR-T cell therapy development
Clinical aspects of oncologic immunotherapy
Nanomedicine and gene delivery: how to move from design to final products

16.30-17.00

17.00-17.30

17.30-18.30

09.30-10.30
Title to be defined
Open Questions on LNP-RNA Structure-Activity Relationship

10.30-11.00

11.00-12.00
Title to be defined
Title to be defined

12.00-12.30

12.30-13.00

13.00-14.30

14.30-16.00
Electroporation based application for the immunotherapy
Tumor microenvironment biomarkers predict response to cancer (nano)therapy
Tunable Paclitaxel-Loaded Lipid Nanoparticle Hydrogel for Intimal Hyperplasia Prevention

16.00-16.30

16.30-17.30
Exploring Hyaluronic Acid-Conjugates for Glioblastoma Local Chemo-Immunotherapy
Chemically mannosylated elastin-like recombinamers as potential novel glycol-nanovaccines against tuberculosis

17.30-18.00

09.30-11.00
Antibody-based antiviral immunotherapy: insights from non-human primate models
Engineering Insoluble Cues for Stem Cell Fate Control and Therapy
Nanomaterials and Smart Manufacturing of Organoids for Advanced Regenerative Medicine
Nitric Oxide nanoparticles for cancer therapy

11.00-11.30

11.30-12.30

12.30-13.00

13.00
Only for Pedagogic committee
